2019 Onco-Nephrology Symposium

2019 Onco-Nephrology Symposium is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held on Dec 07, 2019 at Mortimer B. Zuckerman Research Center, New York City, New York, United States of America.

Specialties:
Bioethics, Cardiology, Critical Care, General and Family Practice, Hospitalist, Internal Medicine , Medical Oncology, Nephrology, Urology

Accreditation:
AMA Credit Designation Statement
Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.00 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Overview:
At least 1 out of every 10 cancer patients will experience acute kidney injury and up to 25% will have chronic kidney disease. Cancer is a common global problem, and as cancer treatments evolve, the nephrologist will be tasked with diagnosing and managing more complex cases within this subgroup of patients.

The 2019 Onco-Nephrology Symposium will offer up to date information and insights from national and international experts in this constantly evolving subspecialty. This goal of this forum is to provide an opportunity for academicians and clinicians to have personal exchanges with experts in this steadily expanding sub specialty in order to enhance the clinical experience of our cancer patients.

This symposium is intended for physicians, advanced practice providers, nurses, medical students and other healthcare professionals in Hospital Medicine, Internal Medicine, Nephrology and Oncology.

Objectives:
• Explore newer biologic agents, with a focus on CAR T cell therapy
• Examine cardio-renal syndromes
• Exchange views on ethical decision making in cancer patients regarding the initiation and termination of dialysis
• Review surgical approaches to renal masses
• Review unique causes of acute and chronic kidney injury in cancer patients

Additional details available here: mskcc.org/NephrologyCourse